These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Long-term usefulness of thioridazine for institutionalized mentally retarded patients.
    Author: Heistad GT, Zimmermann RL, Doebler MI.
    Journal: Am J Ment Defic; 1982 Nov; 87(3):243-51. PubMed ID: 7180884.
    Abstract:
    Thioridazine (Mellaril) medication was discontinued for 4 to 5 weeks for 106 institutionalized mentally retarded patients after an extended period of previous drug treatment. Time-sampling of behavior while patients were receiving medication and while receiving placebo showed a significant increase in self-stimulation and active negative behavior and decreased work and life skills while receiving placebo. Although most patients' behavior was better while on active medication, some showed significant improvement when medication was temporarily discontinued. Favorable long-term progress among those who had medication restored was greater for patients whose behavior had worsened to the greatest degree during the placebo trial.
    [Abstract] [Full Text] [Related] [New Search]